Featured Research

from universities, journals, and other organizations

Steroid Injections Do Not Provide Long-term Relief From Tennis Elbow, Study Says

Date:
October 7, 2006
Source:
BMJ-British Medical Journal
Summary:
Physiotherapy or a "wait and see" approach are both more effective in tackling tennis elbow than corticosteroid injections, a British Medical Journal study reveals. Researchers in Australia tested different treatments on three separate groups of patients with tennis elbow. One group of participants were allocated the "wait and see" approach -- they were reassured that the condition would eventually settle down and encouraged to wait. They were also given specific instructions on modifying their daily activities so to avoid aggravating their pain.

Physiotherapy or a 'wait and see' approach are both more effective in tackling tennis elbow than corticosteroid (steroid) injections, a British Medical Journal study reveals.

Researchers in Australia tested different treatments on three separate groups of patients with tennis elbow. One group of participants were allocated the 'wait and see' approach -- they were reassured that the condition would eventually settle down and encouraged to wait. They were also given specific instructions on modifying their daily activities so to avoid aggravating their pain.

A second group were given a local corticosteroid injection and advised to gradually return to normal activities. The final group received eight treatments of physiotherapy of 30 minutes over six weeks and were taught home exercises and self-manipulation. The physiotherapy group also received a resistant exercise band and exercise instruction booklet. Each group's progress was measured at six weeks, and again after a year.

Initially, corticosteroid injections were the most successful treatment, with 78% of those in the group reporting improvements, followed closely by physiotherapy with a 65% success rate when compared to just 27% in the 'wait and see' group.

However, after 52 weeks the injection group rates of improvement were significantly worse than those of the physiotherapy group. The injection group also had the most reported recurrences, with 72% of participants' condition deteriorating after three or six weeks -- which could be due, in part, to a quicker initial recovery leading to greater use and over-taxing of the elbow.

The research also found that the superior long-term effects of physiotherapy were replicated by the wait and see approach -- at the end of the study participants in both the physiotherapy and wait and see group had either much improved or completely recovered.

The authors say that "the...poor overall performance of corticosteroid injections should be taken under consideration by both the patient and their doctor in management of tennis elbow."

The study findings also support the idea that tennis elbow is, in most cases, a self-limiting condition. They conclude that "patients with tennis elbow can be reassured that, in the majority of cases, they will improve in the long-term when given information and ergonomic advice about their condition."


Story Source:

The above story is based on materials provided by BMJ-British Medical Journal. Note: Materials may be edited for content and length.


Cite This Page:

BMJ-British Medical Journal. "Steroid Injections Do Not Provide Long-term Relief From Tennis Elbow, Study Says." ScienceDaily. ScienceDaily, 7 October 2006. <www.sciencedaily.com/releases/2006/09/060929093850.htm>.
BMJ-British Medical Journal. (2006, October 7). Steroid Injections Do Not Provide Long-term Relief From Tennis Elbow, Study Says. ScienceDaily. Retrieved July 30, 2014 from www.sciencedaily.com/releases/2006/09/060929093850.htm
BMJ-British Medical Journal. "Steroid Injections Do Not Provide Long-term Relief From Tennis Elbow, Study Says." ScienceDaily. www.sciencedaily.com/releases/2006/09/060929093850.htm (accessed July 30, 2014).

Share This




More Health & Medicine News

Wednesday, July 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Concern Grows Over Worsening Ebola Crisis

Concern Grows Over Worsening Ebola Crisis

AFP (July 30, 2014) Pan-African airline ASKY has suspended all flights to and from the capitals of Liberia and Sierra Leone amid the worsening Ebola health crisis, which has so far caused 672 deaths in Guinea, Liberia and Sierra Leone. Duration: 00:43 Video provided by AFP
Powered by NewsLook.com
At Least 20 Chikungunya Cases in New Jersey

At Least 20 Chikungunya Cases in New Jersey

AP (July 30, 2014) At least 20 New Jersey residents have tested positive for chikungunya, a mosquito-borne virus that has spread through the Caribbean. (July 30) Video provided by AP
Powered by NewsLook.com
Generics Eat Into Pfizer's Sales

Generics Eat Into Pfizer's Sales

Reuters - Business Video Online (July 29, 2014) Pfizer, the world's largest drug maker, cut full-year revenue forecasts because generics could cut into sales of its anti-arthritis drug, Celebrex. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins